Resources

A clinical cytogenetics lab performs an in vitro prenatal diagnostic procedure comparing cell-free fetal DNA (cffDNA) testing via maternal plasma shotgun sequencing with conventional G-banded karyotyping from amniocentesis. In maternal plasma at 11 weeks of gestation, total cell-free DNA concentration is 12.0 ng/mL12.0\text{ ng/mL}, with a fetal fraction (FF) of f=0.0800f = 0.0800 (8.00%8.00\%). For an autosomal trisomy (e.g., Trisomy 21), let the expected representation of chromosome 21 reads relative to total genomic reads be modeled as Rtrisomy=Reuploid(1+f2)R_{\text{trisomy}} = R_{\text{euploid}} \left(1 + \frac{f}{2}\right). Given that the baseline euploid chromosome 21 read fraction is Reuploid=0.013000R_{\text{euploid}} = 0.013000, calculate: (a) the expected chromosome 21 read fraction RtrisomyR_{\text{trisomy}} in this maternal plasma sample, and (b) contrast the non-invasive nature of cffDNA with its key diagnostic limitation relative to amniocentesis karyotyping in distinguishing full trisomy from balanced Robertsonian translocations or placental mosaicism.

Answer and steps

Final answer

(a) Rtrisomy=0.013520R_{\text{trisomy}} = 0.013520; (b) cffDNA derives primarily from apoptotic placental trophoblasts rather than fetal tissues directly (leading to false positives from confined placental mosaicism) and cannot determine structural chromosomal architecture or balanced translocations, requiring amniocentesis karyotype confirmation.

Steps

Part (a): Calculating the Expected Read Fraction (RtrisomyR_{\text{trisomy}})

  1. Understand the quantitative effect of trisomy on cell-free DNA (cfDNA): Maternal plasma contains a mixture of maternal cfDNA (fraction 1−f1 - f) and fetal cfDNA (fraction ff).

    • In a normal euploid fetus, both maternal and fetal genomes are disomic (22 copies of chromosome 21).
    • In a fetus with trisomy 21, the fetal contribution contains 33 copies of chromosome 21 instead of 22, an increase of 3−22=12\frac{3 - 2}{2} = \frac{1}{2} (a 50%50\% increase) in the fetal compartment.
    • Therefore, the relative genomic representation increases by f2\frac{f}{2}, yielding the model: Rtrisomy=Reuploid(1+f2)R_{\text{trisomy}} = R_{\text{euploid}} \left(1 + \frac{f}{2}\right)
  2. Substitute the given values into the formula:

    • Baseline euploid fraction: Reuploid=0.013000R_{\text{euploid}} = 0.013000
    • Fetal fraction: f=0.0800f = 0.0800

    1+f2=1+0.08002=1+0.0400=1.04001 + \frac{f}{2} = 1 + \frac{0.0800}{2} = 1 + 0.0400 = 1.0400

    Rtrisomy=0.013000×1.0400=0.013520R_{\text{trisomy}} = 0.013000 \times 1.0400 = 0.013520

(Note: The total cfDNA concentration of 12.0 ng/mL12.0\text{ ng/mL} confirms sufficient yield for sequencing, but the proportional read representation depends entirely on the fetal fraction ff.)


Part (b): Diagnostic Limitations of cffDNA vs. Karyotyping

  • Non-invasive nature vs. tissue origin: cffDNA testing (non-invasive prenatal screening, NIPS) requires only a peripheral maternal blood draw, posing no risk of miscarriage. However, "fetal" cfDNA is actually derived from the apoptosis of placental syncytiotrophoblasts, not the fetus itself. Because of this:

    • Confined Placental Mosaicism (CPM): Chromosomal abnormalities confined solely to the placenta can produce false-positive screening results, while normal placental cells paired with an affected fetus can yield false-negative results.
  • Structural resolution vs. conventional karyotyping:

    • Counting-based shotgun sequencing quantifies total read depth per chromosome but does not visualize individual chromosome architecture. It cannot identify the physical arrangement of chromosomes, such as distinguishing free trisomy 21 from an unbalanced or balanced Robertsonian translocation (e.g., der(14;21)\text{der}(14;21)).
    • In contrast, invasive diagnostic testing via amniocentesis harvests intact, viable fetal amniocytes. G-banded karyotyping directly visualizes structural arrangements, breaks, and mosaic levels across cultured cell colonies, serving as the definitive diagnostic standard.

Typical errors

OverviewACEpath Teacher's Diagnosis

01 The student forgets that the extra chromosome in trisomy adds half of the fetal contribution (f/2) and instead adds the full fetal fraction (f), yielding an overestimated read fraction.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    Rtrisomy=Reuploid×(1+f)  ⟹  Rtrisomy=0.013000×(1+0.0800)=0.014040R_{\text{trisomy}} = R_{\text{euploid}} \times (1 + f) \implies R_{\text{trisomy}} = 0.013000 \times (1 + 0.0800) = 0.014040

    Correct

    Rtrisomy=Reuploid(1+f2)=0.013000×(1+0.0400)=0.013520R_{\text{trisomy}} = R_{\text{euploid}} \left(1 + \frac{f}{2}\right) = 0.013000 \times (1 + 0.0400) = 0.013520

    You omitted the factor of 12\frac{1}{2} applied to the fetal fraction ff. In trisomy 21, the fetus has 3 copies instead of 2, representing a proportional increase of 3−22=12\frac{3 - 2}{2} = \frac{1}{2} (a 50%50\% increase) within the fetal compartment alone, so the excess signal contributed by the fetus is f2\frac{f}{2}.

  2. Step 2

    cffDNA is non-invasive because it only requires a maternal blood draw, avoiding amniocentesis procedural risks. However, cffDNA is derived from placental trophoblasts and measures read counts rather than structural arrangements, so it cannot detect balanced Robertsonian translocations or rule out confined placental mosaicism.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly explained why maternal plasma testing is non-invasive compared to amniocentesis.

You clearly identified that cffDNA originates from placental trophoblasts, leading to limitations like confined placental mosaicism.

You recognized that read-counting approaches cannot resolve physical chromosome structures or balanced Robertsonian translocations.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Omission of Fractional Fetal Allele Increase

no

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

You treated the fetal fraction as adding an entirely redundant disomic genome equivalent (+f+f) rather than accounting for the single extra chromosome copy out of two normal homologues (+f2+\frac{f}{2}).

REASONING PATH
Your ACEpath teacher’s suggested approach
Aneuploidy Fractional Increase
  • For a standard disomic organism, an extra chromosome adds 3−22=12\frac{3 - 2}{2} = \frac{1}{2} relative to the normal diploid fetal contribution, producing a net read increase of f2\frac{f}{2}.

  • Always verify whether the fetal fraction is scaled by the fractional change in copy number: ΔC2×f\frac{\Delta C}{2} \times f, where ΔC=1\Delta C = 1 for trisomy and ΔC=−1\Delta C = -1 for monosomy.

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Apply the given trisomy read representation model: Rtrisomy=Reuploid(1+f2)R_{\text{trisomy}} = R_{\text{euploid}} \left(1 + \frac{f}{2}\right).

  2. Substitute the baseline fraction Reuploid=0.013000R_{\text{euploid}} = 0.013000 and fetal fraction f=0.0800f = 0.0800: Rtrisomy=0.013000×(1+0.0400)R_{\text{trisomy}} = 0.013000 \times (1 + 0.0400).

  3. Multiply to find the expected read fraction: 0.013000×1.0400=0.0135200.013000 \times 1.0400 = 0.013520.

Final answer

(a) Rtrisomy=0.013520R_{\text{trisomy}} = 0.013520; (b) cffDNA is non-invasive via maternal venipuncture, but because it derives from placental trophoblasts and quantifies read depth without structural karyotype visualization, it cannot rule out confined placental mosaicism or detect balanced Robertsonian translocations.

NEXT STEPS
Final Takeaways from Your Teacher
  • Practice deriving fractional representation formulas for different fetal copy-number states (such as monosomy, trisomy, and triploidy).

  • Review the physical basis of fetal fraction scaling to distinguish total cell-free DNA from the specific proportional increase in target chromosome reads.

OverviewACEpath Teacher's Diagnosis

02 The student misinterprets the 8.00% fetal fraction as 0.800 rather than 0.0800, leading to an artificially high read fraction.

Sample Student Work

Reviewed by ACEpath Teacher
Step-by-Step Review
Walk Through It with Your Teacher
Partially correct
  1. Step 1

    f=0.800  ⟹  Rtrisomy=0.013000×(1+0.800/2)=0.013000×1.400=0.018200f = 0.800 \implies R_{\text{trisomy}} = 0.013000 \times (1 + 0.800/2) = 0.013000 \times 1.400 = 0.018200

    Correct

    f=0.0800  ⟹  Rtrisomy=0.013000×(1+0.0800/2)=0.013000×1.0400=0.013520f = 0.0800 \implies R_{\text{trisomy}} = 0.013000 \times (1 + 0.0800/2) = 0.013000 \times 1.0400 = 0.013520

    You correctly set up the mathematical model Rtrisomy=Reuploid(1+f2)R_{\text{trisomy}} = R_{\text{euploid}} \left(1 + \frac{f}{2}\right), but you converted 8.00%8.00\% to 0.8000.800 instead of 0.08000.0800. A fetal fraction of 0.8000.800 represents 80%80\%, which inflated your multiplier from 1.04001.0400 to 1.4001.400.

  2. Step 2

    cffDNA is non-invasive because it samples circulating cell-free DNA from maternal venous blood without needle puncture of the amniotic sac. A major diagnostic limitation is that cffDNA reflects placental apoptosis and only counts genomic dosage, meaning it cannot visualize chromosomal structural rearrangements like balanced translocations or confirm true fetal lineage versus placental mosaicism.

WHAT YOU DID WELL
Compliments from Your Teacher

You correctly identified and applied the mathematical formula for autosomal trisomy read fraction.

You clearly explained why cffDNA sampling is non-invasive compared to amniocentesis.

You thoroughly identified the clinical and biological limitations of cffDNA, including placental mosaicism and structural rearrangement detection.

THE ERROR
Where Your ACEpath Teacher Spotted the Mistake
Decimal place value error in percentage conversion

You wrote 8.00%8.00\% as 0.8000.800 instead of 0.08000.0800, shifting the decimal point one place to the right.

WHY IT HAPPENED
ACEpath Teacher's Diagnosis

Conflating single-digit percentages (e.g., 8%=0.088\% = 0.08) with tenths (e.g., 80%=0.8080\% = 0.80) when converting percentages to decimals in clinical quantitative genetics formulas.

REASONING PATH
Your ACEpath teacher’s suggested approach
Percentage-to-Decimal Conversion Check
  • To convert a percentage to a decimal, divide by 100100 (move the decimal point two places to the left): x%=x100x\% = \frac{x}{100}.

  • Always verify biological plausibility: early pregnancy fetal fractions are typically 4%–15%4\%\text{--}15\% (0.04–0.150.04\text{--}0.15), never 80%80\% (0.800.80).

CORRECTED PATH
ACEpath Teacher's Demonstration
  1. Express the fetal fraction ff as a decimal: f=8.00%=8.00100=0.0800f = 8.00\% = \frac{8.00}{100} = 0.0800.

  2. Calculate the trisomy dosage factor: 1+f2=1+0.08002=1+0.0400=1.04001 + \frac{f}{2} = 1 + \frac{0.0800}{2} = 1 + 0.0400 = 1.0400.

  3. Multiply by the baseline euploid read fraction: Rtrisomy=0.013000×1.0400=0.013520R_{\text{trisomy}} = 0.013000 \times 1.0400 = 0.013520.

Final answer

(a) Rtrisomy=0.013520R_{\text{trisomy}} = 0.013520; (b) cffDNA derives primarily from apoptotic placental trophoblasts rather than fetal tissues directly (leading to false positives from confined placental mosaicism) and cannot determine structural chromosomal architecture or balanced translocations, requiring amniocentesis karyotype confirmation.

NEXT STEPS
Final Takeaways from Your Teacher
  • Double-check percentage-to-decimal conversions by dividing by 100100 before plugging values into dosage equations.

  • Sanity-check fetal fraction values against clinical ranges, recognizing that maternal plasma is overwhelmingly maternal DNA (>85%>85\%).

Lock it in

Similar question

01

A maternal plasma sample at 12 weeks of gestation has a fetal fraction of f=0.1200f = 0.1200. If the baseline euploid read fraction for chromosome 18 is Reuploid=0.028000R_{\text{euploid}} = 0.028000, calculate the expected read fraction RtrisomyR_{\text{trisomy}} in a pregnancy affected by Trisomy 18.

Answer

Rtrisomy=0.029680R_{\text{trisomy}} = 0.029680. Key step: Calculate the scaling factor 1+f2=1+0.12002=1.06001 + \frac{f}{2} = 1 + \frac{0.1200}{2} = 1.0600, then multiply 0.028000×1.0600=0.0296800.028000 \times 1.0600 = 0.029680.

02

In a screening test for Monosomy 21 (loss of one copy of chromosome 21), maternal plasma sequencing yields an observed read fraction of Robserved=0.012350R_{\text{observed}} = 0.012350, while the normal euploid reference is Reuploid=0.013000R_{\text{euploid}} = 0.013000. Assuming the model Rmonosomy=Reuploid(1−f2)R_{\text{monosomy}} = R_{\text{euploid}} \left(1 - \frac{f}{2}\right), calculate the estimated fetal fraction ff.

Answer

f=0.1000f = 0.1000 (10.0%10.0\%). Key step: Set up 1−f2=0.0123500.013000=0.9500  ⟹  f2=0.0500  ⟹  f=0.10001 - \frac{f}{2} = \frac{0.012350}{0.013000} = 0.9500 \implies \frac{f}{2} = 0.0500 \implies f = 0.1000.

03

A non-invasive prenatal screening (NIPS) result indicates high risk for Trisomy 13, but subsequent G-banded karyotyping from amniocentesis demonstrates a normal 46,XX46,\text{XX} fetal constitution. (a) Name the biological phenomenon involving placental lineage divergence that most commonly accounts for this discordant result. (b) Explain why chorionic villus sampling (CVS) could also yield a misleading result in this scenario, whereas amniocentesis provides the definitive diagnosis.

Answer

(a) Confined placental mosaicism (CPM). (b) CVS samples chorionic villi derived from the same outer trophoblast/extraembryonic lineage as cffDNA, thus replicating the abnormal placental cell line. In contrast, amniocentesis samples amniocytes derived from the inner cell mass/epiblast, directly reflecting true fetal chromosomal constitution.

Loading workspace…